Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
2016 ◽
Vol 22
(7)
◽
pp. 1333-1337
◽
2014 ◽
Vol 20
(2)
◽
pp. S72
2006 ◽
Vol 12
(6)
◽
pp. 599-602
◽
2008 ◽
Vol 142
(5)
◽
pp. 848-850
◽
2015 ◽
Vol 21
(2)
◽
pp. S85-S86
2009 ◽
pp. 287-291
2004 ◽
Vol 33
(6)
◽
pp. 613-622
◽